Trust and anxiety as primary drivers of digital health acceptance in multiple sclerosis: toward an extended disease-specific technology acceptance model - Top-Institutions - MDSpire

Trust and anxiety as primary drivers of digital health acceptance in multiple sclerosis: toward an extended disease-specific technology acceptance model

  • By

  • Felix Höpfl

  • Mira Brundiers

  • March 13, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research
    Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research

    Cleveland, OH

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Digital Health
    • Behavioral Neurology

  • #2

    Brigham and Women's Hospital - Partners MS Center
    Brigham and Women's Hospital - Partners MS Center

    Boston, MA

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Digital Health
    • Neuroimmunology

  • #3

    University of California, San Francisco (UCSF) Multiple Sclerosis Center
    University of California, San Francisco (UCSF) Multiple Sclerosis Center

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Digital Health
    • Neuropsychology

  • #4

    Mayo Clinic Multiple Sclerosis Center
    Mayo Clinic Multiple Sclerosis Center

    Rochester, MN

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Digital Health
    • Rehabilitation Medicine

  • #5

    Northwestern University Multiple Sclerosis Program
    Northwestern University Multiple Sclerosis Program

    Chicago, IL

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Digital Health
    • Behavioral Science

Original Source(s)

Trust and anxiety as primary drivers of digital health acceptance in multiple sclerosis: toward an extended disease-specific technology acceptance model

  • by Felix Höpfl, Mira Brundiers

  • March 13, 2026

Related Content

Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights